Cargando…
Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797704/ https://www.ncbi.nlm.nih.gov/pubmed/20030876 http://dx.doi.org/10.1186/bcr2443 |
_version_ | 1782175657998942208 |
---|---|
author | Gutteridge, Eleanor Robertson, John FR |
author_facet | Gutteridge, Eleanor Robertson, John FR |
author_sort | Gutteridge, Eleanor |
collection | PubMed |
description | |
format | Text |
id | pubmed-2797704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27977042009-12-25 Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors Gutteridge, Eleanor Robertson, John FR Breast Cancer Res Short Communication BioMed Central 2009 2009-12-18 /pmc/articles/PMC2797704/ /pubmed/20030876 http://dx.doi.org/10.1186/bcr2443 Text en Copyright ©2009 BioMed Central Ltd |
spellingShingle | Short Communication Gutteridge, Eleanor Robertson, John FR Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors |
title | Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors |
title_full | Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors |
title_fullStr | Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors |
title_full_unstemmed | Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors |
title_short | Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors |
title_sort | are current drug development programmes realising the full potential of new agents? tyrosine kinase inhibitors |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797704/ https://www.ncbi.nlm.nih.gov/pubmed/20030876 http://dx.doi.org/10.1186/bcr2443 |
work_keys_str_mv | AT gutteridgeeleanor arecurrentdrugdevelopmentprogrammesrealisingthefullpotentialofnewagentstyrosinekinaseinhibitors AT robertsonjohnfr arecurrentdrugdevelopmentprogrammesrealisingthefullpotentialofnewagentstyrosinekinaseinhibitors |